Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Spiriva Respimat in Severe Persistent Asthma
NCT00776984Phase 3Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Oct 2008
- Primary completion
- Jul 2011
- Modality
- Small Molecules
- Countries
- 15
01
Overview
A Phase 3 trial of tiotropium in severe asthma, sponsored by Boehringer Ingelheim. Started Oct 2008; status: completed.
02
Drugs
tiotropium
03
Conditions
severe asthma
Beyond the preview
Go deeper on NCT00776984.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00776984.